Trial Outcomes & Findings for Circulation Improving Resuscitation Care (CIRC) (NCT NCT00597207)
NCT ID: NCT00597207
Last Updated: 2018-07-24
Results Overview
Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
4231 participants
Primary outcome timeframe
From time of first contact until hospital discharge, up to 90 days.
Results posted on
2018-07-24
Participant Flow
Participant milestones
| Measure |
iA-CPR
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
|---|---|---|
|
Overall Study
STARTED
|
2099
|
2132
|
|
Overall Study
COMPLETED
|
2094
|
2125
|
|
Overall Study
NOT COMPLETED
|
5
|
7
|
Reasons for withdrawal
| Measure |
iA-CPR
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
5
|
7
|
Baseline Characteristics
Circulation Improving Resuscitation Care (CIRC)
Baseline characteristics by cohort
| Measure |
iA-CPR
n=2099 Participants
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
n=2132 Participants
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
Total
n=4231 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
18-59 years
|
706 participants
n=5 Participants
|
734 participants
n=7 Participants
|
1440 participants
n=5 Participants
|
|
Age, Customized
60-74 years
|
671 participants
n=5 Participants
|
689 participants
n=7 Participants
|
1360 participants
n=5 Participants
|
|
Age, Customized
75+ years
|
722 participants
n=5 Participants
|
709 participants
n=7 Participants
|
1431 participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
784 Participants
n=5 Participants
|
837 Participants
n=7 Participants
|
1621 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1315 Participants
n=5 Participants
|
1295 Participants
n=7 Participants
|
2610 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: From time of first contact until hospital discharge, up to 90 days.Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.
Outcome measures
| Measure |
iA-CPR
n=2094 Participants
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
n=2125 Participants
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
|---|---|---|
|
Hospital Discharge
|
196 participants
|
233 participants
|
Adverse Events
iA-CPR
Serious events: 11 serious events
Other events: 242 other events
Deaths: 0 deaths
M-CPR
Serious events: 1 serious events
Other events: 225 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
iA-CPR
n=2099 participants at risk
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
n=2132 participants at risk
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
|---|---|---|
|
Injury, poisoning and procedural complications
CPR related injuries
|
0.52%
11/2099 • Number of events 11
|
0.05%
1/2132 • Number of events 1
|
Other adverse events
| Measure |
iA-CPR
n=2099 participants at risk
Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression
|
M-CPR
n=2132 participants at risk
Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression
|
|---|---|---|
|
Injury, poisoning and procedural complications
Pneumothorax
|
1.6%
33/2099 • Number of events 33
|
0.94%
20/2132 • Number of events 20
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary edema
|
7.6%
159/2099 • Number of events 159
|
8.3%
176/2132 • Number of events 176
|
|
Injury, poisoning and procedural complications
Rib Fractures
|
3.3%
69/2099 • Number of events 69
|
1.5%
31/2132 • Number of events 31
|
|
Injury, poisoning and procedural complications
Subcutaneous emphysema
|
1.0%
21/2099 • Number of events 21
|
0.28%
6/2132 • Number of events 6
|
Additional Information
Sr. Director of Clinical Research
ZOLL Medical Corporation
Phone: 978-421-9655
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60